Abstract : The essential oil (EO) obtained from Cymbopogon nardus is used frequently as ingredients of anti-AIDS medication in Africa by indigenous people who rely mainly on traditional medicinal plant therapies. However, its mechanism still remains obscure. The present study investigated the biological effects of the EO derived from C. nardus collected in Benin on the activities of human immunodeficiency virus reverse transcriptase (HIV-1 RT) and Escherichia coli DNA polymerase I (DNA-POL I). Biochemical experiments showed that C. nardus EO inhibited the activity of HIV-1 RT, whereas it had no effect on DNA-POL I. To investigate the specificity of these biological effects of C. nardus, six other representatives EOs were assayed in the same way in order to determine their effects on HIV-1 RT and DNA-POL I. None of the other six EOs had significant effect on the activities of these two enzymes. Gas chromatography-mass spectrometry analysis of the EO obtained from the aerial parts of C. nardus by steam distillation identified among other constituents: (S)-β-citronellol, (R)-linalool, (R)-limonene, geraniol and (R)-citronellal. In particular, (S)-β-citronellol inhibited HIV-1 RT in vitro biochemical assay where the same concentration as C. nardus EO was used in the experiment.
INTRODUCTION
Early in 1981, acquired immunodeficiency syndrome (AIDS) emerged suddenly among homosexuals and injected drug users in the United States (Gottlieb et al. 2006 , Sharp et al. 2011 ). Subsequently, AIDS spread rapidly to become a global public health pandemic. Montagnier et al. The standard cocktail therapy (highly active antiretroviral therapy, HAART) used recently in developed countries is very effective in suppressing viral replication and it has significantly reduced the mortality rate of HIV/AIDS patients, as well as improving their quality of life (Antonella et al. problems (Cohen et al. 2008 , World Health Organization 2011, World Health Organization 2012). These problems include a major lack of adequate therapy due to the high costs of anti-AIDS drugs, the unavailability of anti-AIDS drugs and various complex side effects, such as the emergence of anti-AIDS drug resistance (Hawkins 2006 Ziske et al. 2013) . In this problematic background, african communities have developed many effective natural medicines from traditional therapeutic plants ( Leteane et al. 2012) . Cymbopogon nardus (C. nardus) is a perennial grass in the Poaceae family, which grows in tropical areas such as Sri Lanka, Africa, and Java and it is one of the most frequently used plants in traditional anti-AIDS drug preparations. The essential oil (EO) obtained from the leaves and stems of C. nardus by steam distillation has also been used to treat infections in the past in Africa (Wei et al. 2013 ). However, the mechanism that underlies its therapeutic efficacy still remains obscure.
In the present study, an in vitro biochemical investigation showed that the EO derived from C. nardus inhibited HIV-1 RT activity in a dose-dependent manner. Gas chromatography-mass spectrometry (GC-MS) analysis of this EO sample identified several constituents and their activities were assayed against HIV-1 RT and Escherichia coli DNA polymerase I (DNA-POL I). The results showed that (S)-β-citronellol might be one of the constituents of C. nardus with inhibitory effects on HIV-1 RT.
MATERIALS AND METHODS

Reagents
C. nardus EO, Ocimum gratissimum EO, Lippia multiflora EO, C. citratus EO, Melaleuca viridiflora leaf EO and Eucalyptus obliqua leaf EO were all steam distilled extracts from these plants, which were purchased from Aronat + (Benin). Commercial (R)-citronellal (purity >90% by GC), (R)-linalool (purity >98% by GC), geraniol (purity >97% by GC) and (R)-limonene (purity >95% by GC) were purchased from Wako. (S)--citronellol (purity >95% by GC) was purchased from Tokyo Chemical Industry Co. Ltd. ddTTP (purity 99% by HPLC) was purchased from Amsterdam Biosciences inhibition assay. Neomycin trisulfate salt hydrate (potency > 600 g per mg) was purchased from Sigma-Aldrich. The RT assay colorimetric kit, biotin-16-dUTP, digoxigenin deoxyuridine triphosphate (DIG-dUTP), DNA-dependent DNA-POL I from Escherichia coli lysogenic NM 964, deoxynucleoside triphosphate set (PCR grade) and hexanucleotide mix (10 concentration) were purchased from Roche. Single-stranded DNA from calf thymus (purity >65%) was purchased from Sigma-Aldrich.
Evaluation of HIV-1 RT Inhibitory Effect
The quantitative determination of the HIV-1 RT inhibitory effect of EO used a colorimetric enzyme immunoassay, which involved the incorporation of DIG-and biotin-labeled dUTP into native DNA. The assay was performed with an RT assay colorimetric kit, according to the manufacturer's instructions with slight modifications. Briefly, 60 L of a reaction mixture containing final concentrations of 46 mM Tris-HCl, 266 mM KCl, 27.5 mM MgCl 2 , 9.2 mM dithiothreitol (DTT), 10 M biotin-16-dUTP/DIG-dUTP, 2.2 μg/mL PolyA:oligo (dT) 15 template/primer hybrid, 1.7 ng/mL HIV-1 RT and various concentrations of sample (0.1-10 mg/mL) was incubated at 37°C for 15 h. The reaction mixture was transferred to the surface of streptavidin-coated ELISA plate wells. After washing away any unbound substances, an antibody directed against DIG conjugated to peroxidase (anti-DIG-POD) was added that bound to DIG-11-dTTP. After one more wash, 2,2-azinobis (3-ethylbenzothiazoline-6-sulphonic acid) diammonium salt (ABTS) was added. The absorbance (OD 405nm ) of the color that developed in the presence of ABTS was evaluated at 405 nm using an Enzyme-Linked Immunosorbent Assay (ELISA) microplate reader (SpectraMax 340PC). A reaction solution where the inhibitor was replaced with dilution buffer was used as the control. A sample without RT solution was used as the negative control and a sample with 2 M ddTTP was used as the positive control. EOs were dissolved in ethanol to prepare a dilution series that ranged from 0.1 mg/mL to 10 mg/mL. The final ethanol concentration in the solutions was <1%, which had no effect on the assay results. The inhibitory effects of RT inhibitors were calculated as the percentage inhibition relative to the control, as follows:
Control relative percentage of inhibition = 100 -[ ( Sample OD 405nm -Negative control OD 405nm ) / (Control OD 405nm -Negative control OD 405nm ) ]  100.
Evaluation of DNA-POL I Activity
Evaluations of the effects of EOs on the activity of DNA-POL I were performed as described by Ducancelle et al., with slight modifications (Ducancelle et al. 2007 ). The DNA-POL I activity was assayed by measuring the incorporation of DIG-dUTP into the complementary DNA chain. Calf thymus DNA was used as the template with a mixture of hexanucleotides designed as random primers. Briefly, 20 L of a reaction mixture containing final concentrations of 50 g/mL calf thymus DNA, 50 mM Tris-HCl (pH7.2), 10 mM MgCl 2 , 0.1 mM DTT, 0.2 mg/mL Bovine serum albumin (BSA), dATP, dGTP, dCTP, dTTP, DIG-dUTP, biotin-16-dUTP and various concentrations of inhibitor (0.1-10 mg/mL) was incubated at 37°C for 15 h. The subsequent steps were performed in the same manner as the "Evaluation of HIV-1 RT inhibitory effect" described above. A sample without DNA-POL I solution was used as the negative control and a sample with 10 mM Neomycin trisulfate salt hydrate was used as the positive control. The ethanol concentration in the reaction mixtures was <1%, which had no effect on the activity of DNA-POL I. 2.4. Identification of the Major Constituents of C. Nardus EO C. nardus EO was analyzed by GC-MS, as described by Kudo et al. (2009) , using an Agilent 6890 GC combined with an Agilent 5973 MS. NAGINATA software was provided by Nishikawa. A HP5ms fused silica capillary column (30 m x 0.25 mm i.d., 0.25 m film thickness, Agilent) coated with 5% phenylmethyl-silicone stationary phase was used. The GC-MS data analysis was performed using NIGINATA software based on the ''free-drug database" and the ''drug database with acetylating reagents".
Statistical Analysis
The results were analyzed using the Student's t-test. Differences were considered significant at p < 0.05
RESULTS
Efficacy and toxicity are two indispensable parts of EO activity evaluation, so the biological effects of C. nardus EO on HIV-1 RT were examined to assess its efficacy, whereas its effects on DNA-POL I were assessed to determine its toxicity. C. nardus EO had a dose-dependent inhibitory effect (IC 50 value of 1.2 mg/mL) against HIV-1 RT at concentrations ranged from 0.1 to 10 mg/mL (Fig. 1A) . With 10 mg/mL of C. nardus EO, the activity of HIV-1 RT was significantly inhibited by up to 72.4% compared with the control (p < 0.001). This inhibitory effect was similar to that produced with the positive control (2 μM 2,3-dideoxythymidine-5-triphosphate; ddTTP). In addition, C. nardus EO had no major biological effects on DNA-POL I, while 10 mM Neomycin as a positive control showed clearly that effect. This enzyme retained up to 91.5% of its activity compared with the control when the same concentration as in HIV-1 RT assay of C. nardus EO (10 mg/mL, Fig. 1B To investigate the specificity of the inhibitory activity produced by C. nardus EO on HIV-1 RT and the inhibitory effect against DNA-POL I, six other representatives EOs were assayed in the same way.
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The results are shown in Table 1 . Cymbopogon citratus EO (HIV-1 RT: IC 50 > 10 mg/mL; DNA-POL I: IC 50 = 9.6 mg/mL), Ocimum gratissimum EO (HIV-1 RT: IC 50 > 10 mg/mL; DNA-POL I: IC 50 > 10 mg/mL) had no inhibitory effects on the two enzymes. Eucalyptus obliqua leaf EO (HIV-1 RT: IC 50 = 4.5 mg/mL, DNA-POL I IC 50 >10.0 mg/mL), Melaleuca viridiflora leaf EO (HIV-1 RT: IC 50 = 1.8 mg/mL, DNA-POL I: IC 50 >10.0 mg/mL), and Lippia multiflora EO (HIV-1 RT: IC 50 = 5.5 mg/mL; DNA-P0L I: IC 50 = 9.6 mg/mL) had effects on HIV-1 RT and DNA-POL I but they were weak compared with the effects of C. nardus on the same enzymes. Thus, none of the other six EOs had the same effects on these enzymes as C. nardus EO.
C. nardus EO was subjected to a quantitative GC-MS for analyzing the constituents. The results showed that about 27 peaks were identified (data not shown). Among these, the five commercial available constituents ((R)-linalool, (R)-limonene, geraniol, (R)-Citronellal and (S)-β-citronellol) were selected for further experiments. Then, the activities of these constituents against HIV-1 RT and DNA-POL I were assayed. The results are shown in Table 2 
1.(R)-Linalool, 2.(R)-Limonene, 3.Geraniol, 4.(R)-Citronellal, 5.(S)-β-Citronellol
A) HIV-1 RT B) DNA-dependent DNA polymerase I (2009) showed that the active constituents with inhibitory effects in these oils were dillapiol and myristicin. Similarly, the present study of C. nardus EO showed that the monoterpenoid (S)-β-citronellol (IC 50 = 3.3 mg/mL) present in this EO also inhibited HIV-1 RT in a dose-dependent manner. This inhibitory effect of (S)-β-citronellol on HIV-1 RT activity was specific or at least unique among the C. nardus EO constituents assayed in the present study ( Fig. 3 and Table 2 ).These results suggest that the anti-HIV-1/AIDS effect of C. nardus EO in traditional African medicine may be attributable to the HIV-1 RT inhibitory effect of (S)-β-citronellol contained in this EO. On the other hand, we reported for the first time that Melaleuca viridiflora leaf EO, Eucalyptus obliqua leaf EO and Lippia multiflora EO had shown inhibitory effects against HIV-1 RT activity but this inhibitory effect is weak as compare with that of C. nardus EO. 1, 8 cineol is the main constituent of the essential oil of all eucalyptus species. Although all these works used GC/MS analysis, (S)-β-citronellol had not been reported in any of these EOs. We then thought worth to conclude that the inhibitory activity of Melaleuca quinquenervia EO, Lippia multiflora EO and Eucalyptus obliqua EO against HIV-1 RT should be attributable to an unknown compound different from (S)-β-citronellol. Further studies will be needed to identified the active constituents in the above three EOs. 
Fig3. Biological effects of (S)-β-citronellolon HIV-1 RT and DNA-dependent
DISCUSSION
Table2. Biological effects of various chemical constituents of Cymbopogon nardus on HIV-1 RT and DNA-POL
